Cargando…
Brève : Bloquer l’IL-6 chez les patients atteints de Covid-19 graves ou critiques
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068865/ https://www.ncbi.nlm.nih.gov/pubmed/35529534 http://dx.doi.org/10.1016/S1773-035X(22)00156-3 |
| _version_ | 1784700308391198720 |
|---|---|
| author | Manus, Jean-Marie |
| author_facet | Manus, Jean-Marie |
| author_sort | Manus, Jean-Marie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9068865 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90688652022-05-04 Brève : Bloquer l’IL-6 chez les patients atteints de Covid-19 graves ou critiques Manus, Jean-Marie Rev Francoph Lab Article Elsevier Masson SAS. 2022-05 2022-05-05 /pmc/articles/PMC9068865/ /pubmed/35529534 http://dx.doi.org/10.1016/S1773-035X(22)00156-3 Text en Copyright © 2022 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Manus, Jean-Marie Brève : Bloquer l’IL-6 chez les patients atteints de Covid-19 graves ou critiques |
| title | Brève : Bloquer l’IL-6 chez les patients atteints de Covid-19 graves ou critiques |
| title_full | Brève : Bloquer l’IL-6 chez les patients atteints de Covid-19 graves ou critiques |
| title_fullStr | Brève : Bloquer l’IL-6 chez les patients atteints de Covid-19 graves ou critiques |
| title_full_unstemmed | Brève : Bloquer l’IL-6 chez les patients atteints de Covid-19 graves ou critiques |
| title_short | Brève : Bloquer l’IL-6 chez les patients atteints de Covid-19 graves ou critiques |
| title_sort | brève : bloquer l’il-6 chez les patients atteints de covid-19 graves ou critiques |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068865/ https://www.ncbi.nlm.nih.gov/pubmed/35529534 http://dx.doi.org/10.1016/S1773-035X(22)00156-3 |
| work_keys_str_mv | AT manusjeanmarie brevebloquerlil6chezlespatientsatteintsdecovid19gravesoucritiques |